Pleuroparenchymal fibroelastosis in systemic sclerosis: prevalence and prognostic impact
- 16 April 2020
- journal article
- research article
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (1), 1902135
- https://doi.org/10.1183/13993003.02135-2019
Abstract
Interstitial lung disease (ILD) in systemic sclerosis (SSc) is a major cause of morbidity and mortality, mostly presenting as non-specific interstitial pneumonia. Little is known about the prevalence of pleuroparenchymal fibroelastosis (PPFE), a specific entity affecting the visceral pleura and subpleural parenchyma. We set out to estimate PPFE prevalence in two large cohorts of SSc patients and to assess its impact on survival and functional decline. A total of 359 SSc patients, derived from two referral centres in two different countries (UK and Italy), were included. The first available high-resolution computed tomography scan was independently evaluated by two radiologists blind to clinical information, to quantify ILD extent, freestanding bronchial abnormalities, and lobar percentage involvement of PPFE on a four-point categorical scale. Discordant scores were adjudicated by a third scorer. PPFE extent was further classified as limited (≤2/18) or extensive (>2/18). Results were evaluated against functional decline and mortality. The overall prevalence of PPFE in the combined SSc population was 18% (11% with extensive PPFE), with no substantial difference between the two cohorts. PPFE was significantly linked to free-standing bronchial abnormalities (61% versus 25% in PPFE versus no PPFE; p<0.0001) and to worse survival, independently of ILD severity or short-term lung function changes (HR 1.89, 95% CI 1.10–3.25; p=0.005). In the current study, we provide an exhaustive description of PPFE prevalence and clinical impact in the largest cohort of SSc subjects published so far. PPFE presence should be carefully considered, due to its significant prognostic implications.Keywords
This publication has 28 references indexed in Scilit:
- 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiativeAnnals Of The Rheumatic Diseases, 2013
- An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial PneumoniasAmerican Journal of Respiratory and Critical Care Medicine, 2013
- Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypesEuropean Respiratory Journal, 2012
- Clinical Predictors of Survival in Idiopathic Pulmonary FibrosisTuberculosis and Respiratory Diseases, 2012
- High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: Features and differential diagnosisRespiratory Research, 2011
- Interstitial Lung Disease in Systemic SclerosisAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Changes in causes of death in systemic sclerosis, 1972-2002Annals Of The Rheumatic Diseases, 2007
- Pulmonary Disease Assessment in Cystic Fibrosis: Comparison of CT Scoring Systems and Value of Bronchial and Arterial Dimension MeasurementsRadiology, 2004
- Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to OutcomeAmerican Journal of Respiratory and Critical Care Medicine, 2002